Why the study?
Does a signature of four circulating miRNAs distinguish Takotsubo cardiomyopathy from STEMI?
Population
Patients with Takotsubo cardiomyopathy (TTC) and acute myocardial infarction (STEMI)
Design
Other
Authors
Loading...
May aid acute differentiation of TTC from STEMI; provides first RCT-derived evidence for a four-miRNA signature linked to ET-1.
Does a signature of four circulating miRNAs distinguish Takotsubo cardiomyopathy from STEMI?
A novel signature of four circulating miRNAs can robustly differentiate Takotsubo cardiomyopathy from STEMI, providing a potential new diagnostic biomarker and supporting a microvascular spasm pathophysiological link.
Jaguszewski et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: